Abstract
Ramoplanin, a new depsipeptide complex, was found to be 4- to 8-fold more active than vancomycin against all Gram-positive species (500 strains). Similarly, ramoplanin was both more active and had an additional spectrum compared to mupirocin (formerly pseudomonic acid) against Bacillus spp., Corynebacterium jeikeium, enterococci and Listeria monocytogenes. Mupirocin-resistant Staphylococcus spp. strains (less than 1%) were identified in these organisms collected from over 40 medical centers in the United States. These strains (S. capitis and S. saprophyticus) were susceptible to ramoplanin at 0.25 micrograms/ml or less. The three tested antimicrobial agents were not effective against Gram-negative organisms (20 species tested). Ramoplanin was bactericidal and MICs were not adversely influenced by high (greater than or equal to 10(7) CFU/ml) inoculum concentrations. Because ramoplanin has previously shown promise as a topical drug, these in vitro results further substantiate its wide spectrum, potency, and potential clinical usefulness as mupirocin-resistant staphylococci and other Gram-positive species become more prevalent.
References
Feb 1, 1989·Antimicrobial Agents and Chemotherapy·J O CapobiancoR C Goldman
Jan 1, 1988·The Journal of Antimicrobial Chemotherapy·G E Smith, C T Kennedy
May 1, 1988·The Journal of Antimicrobial Chemotherapy·H RodeS Cywes
Sep 1, 1988·The Journal of Antimicrobial Chemotherapy·R L HillM W Casewell
Nov 1, 1988·The Journal of Antimicrobial Chemotherapy·W C NobleI Phillips
Dec 1, 1988·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S DixsonJ M Hamilton-Miller
Jan 1, 1986·Chemotherapy·H C Neu, N M Neu
Apr 1, 1985·Antimicrobial Agents and Chemotherapy·R SutherlandA R White
Dec 17, 1971·Nature·A T FullerE B Chain
Oct 1, 1984·Antimicrobial Agents and Chemotherapy·R PallanzaV Arioli
Nov 1, 1980·Antimicrobial Agents and Chemotherapy·R D PearsonS W Chapman
Citations
Jun 1, 1993·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A BarryJ McLaughlin
Jul 31, 2013·Biotechnology Letters·Jun-Sheng ChenDai-Jie Chen
Jul 1, 1989·Diagnostic Microbiology and Infectious Disease·R N Jones
Oct 1, 1993·Diagnostic Microbiology and Infectious Disease·R ScottiB P Goldstein
Jan 1, 1993·Diagnostic Microbiology and Infectious Disease·J N RodriguesR N Jones
Feb 1, 1994·Diagnostic Microbiology and Infectious Disease·M T KennyJ K Dulworth
Jun 27, 2007·Journal of the American Chemical Society·Joonwoo NamDale L Boger
Apr 1, 2010·Journal of Natural Products·Xihou YinT Mark Zabriskie
Mar 1, 1991·Antimicrobial Agents and Chemotherapy·R N JonesX Y Zhou
Oct 1, 1992·Antimicrobial Agents and Chemotherapy·C C JohnsonM E Levison
Apr 1, 1993·Antimicrobial Agents and Chemotherapy·T LawrenceD Amsterdam
Jun 1, 1993·Antimicrobial Agents and Chemotherapy·L A CollinsR C Moellering
Jun 25, 2003·Antimicrobial Agents and Chemotherapy·D M CitronE J C Goldstein
Feb 25, 2005·Antimicrobial Agents and Chemotherapy·T PeláezE Bouza
Jul 19, 2013·Future Medicinal Chemistry·Nina BiondaPredrag Cudic
Oct 1, 1995·The American Journal of Medicine·K V RolstonG P Bodey
Jul 28, 2010·FEMS Microbiology Letters·John W SchmidtDewey G McCafferty
Dec 20, 2002·Biopolymers·Dewey G McCaffertyWenkai Li
Apr 1, 1991·Journal of Chemotherapy·A PignatariM A Pfaller
Feb 11, 2005·Chemical Reviews·Suzanne WalkerDale L Boger
Oct 1, 1995·Clinical Microbiology Reviews·N WoodfordD C Speller
May 1, 1994·Journal of Clinical Microbiology·M T Kenny, M A Brackman
Jul 1, 1993·Journal of Clinical Microbiology·A L BarryP C Fuchs
Feb 13, 2003·Journal of the American Chemical Society·Wanlong JiangDale L Boger
May 9, 2002·Journal of the American Chemical Society·Wanlong JiangDale L Boger